Cosmo Pharmaceuticals N.V (C43) — Free Cash Flow Generation Index
Cosmo Pharmaceuticals N.V (C43) has a Free Cash Flow Generation Index of 1.18x as of June 2022. Free cash flow of €7.39 Million represents 1% of operating cash flow (€6.28 Million). Read Cosmo Pharmaceuticals N.V (C43) financial obligations for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Cosmo Pharmaceuticals N.V Free Cash Flow Generation Index (2016–2024)
Historical FCF Generation Index trend for Cosmo Pharmaceuticals N.V across 6 annual periods. Explore capital reinvestment ratio of Cosmo Pharmaceuticals N.V to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for Cosmo Pharmaceuticals N.V (2016–2024)
Year-by-year Free Cash Flow Generation Index for Cosmo Pharmaceuticals N.V. For the full company profile including market capitalisation, see C43 company net worth.
| Year | FCG Index | Free Cash Flow (EUR) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.97x | €156.76 Million | €162.41 Million | €5.65 Million | ▲ +77.2% |
| 2023 | 0.54x | €18.31 Million | €33.62 Million | €15.31 Million | ▼ -30.2% |
| 2022 | 0.78x | €25.92 Million | €33.23 Million | €7.31 Million | ▲ +139.5% |
| 2021 | 0.33x | €4.11 Million | €12.61 Million | €5.49 Million | ▼ -13.7% |
| 2020 | 0.38x | €4.90 Million | €12.98 Million | €4.12 Million | ▼ -79.6% |
| 2016 | 1.85x | €40.12 Million | €21.69 Million | €18.43 Million | — |